Repatha, a cholesterol-lowering medication, has experienced periods of shortage, impacting patient access. These shortages have been attributed to various factors, including increased demand and manufacturing complexities.
Why Has Repatha Been Hard to Find?
Supply disruptions have led to difficulties in obtaining Repatha. For example, in late 2022, reports indicated that certain dosages of Repatha were unavailable, with pharmacies unable to provide an estimated restock date [1]. This scarcity has affected patients across different regions and prompted concerns about consistent treatment adherence.
What Happens When Patients Can't Get Repatha?
When Repatha is unavailable, patients may face challenges in managing their high cholesterol levels. For individuals with very high LDL cholesterol or those at high risk of cardiovascular events, uninterrupted treatment is crucial [2]. Skipping doses or switching to alternative therapies, which may be less effective or have different side effect profiles, can potentially compromise their health outcomes.
What Are Doctors Doing About Repatha Shortages?
Physicians have explored various strategies to manage Repatha shortages. This can include contacting multiple pharmacies to locate available medication, working with the manufacturer for updates on supply, or prescribing alternative lipid-lowering drugs if clinically appropriate [1]. The scarcity has also highlighted the importance of patient communication and education regarding potential treatment interruptions.
When Did Repatha Shortages Start?
While specific start dates for every shortage instance are not detailed, reports of Repatha unavailability have surfaced at various points, including in late 2022. The frequency and duration of these shortages can vary, impacting different formulations and strengths of the drug [1].
Are There Alternatives to Repatha?
Yes, there are alternative medications for managing high cholesterol. These include other classes of drugs like statins, ezetimibe, and PCSK9 inhibitors, although Repatha itself is a PCSK9 inhibitor. The choice of an alternative depends on a patient's specific condition, existing treatments, and tolerance to different medications [2].
How Does Repatha Work?
Repatha (evolocumab) is a monoclonal antibody that works by inhibiting the PCSK9 protein. This inhibition allows more LDL receptors to remain on the surface of liver cells, which in turn removes more LDL cholesterol from the blood [3]. This mechanism makes it particularly effective for lowering LDL cholesterol in individuals with certain genetic predispositions or those who do not respond adequately to other treatments.
Who Makes Repatha?
Repatha is manufactured by Amgen [4].
What Is the Patent Status for Repatha?
Drug patents, including those for Repatha, are complex and can involve multiple patents covering different aspects of the drug, such as its composition, method of use, and manufacturing processes. Information on specific patent expiry dates and potential challenges can be found through specialized patent tracking resources [5].
What Are the Risks of Missing Repatha Doses?
Missing doses of Repatha can lead to an increase in LDL cholesterol levels, potentially negating the therapeutic benefits achieved. This could heighten the risk of cardiovascular events, especially for patients with pre-existing cardiovascular disease or other risk factors [2].
Sources:
[1] https://www.drugpatentwatch.com/blog/drug-shortages/repatha-shortage-patient-impact
[2] https://www.drugpatentwatch.com/blog/drug-shortages/repatha-shortage-patient-impact
[3] https://www.drugpatentwatch.com/blog/drug-shortages/repatha-shortage-patient-impact
[4] https://www.drugpatentwatch.com/blog/drug-shortages/repatha-shortage-patient-impact
[5] https://www.drugpatentwatch.com/